Synucure Therapeutics
Montréal
About Synucure Therapeutics
Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.8M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: synucure.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/synucure-therapeutics-47859 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.